Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial
2011

Bronchodilator Response and Health Outcomes in COPD Patients

Sample size: 5783 publication 10 minutes Evidence: high

Author Information

Author(s): Hanania Nicola A, Sharafkhaneh Amir, Celli Bartolome, Decramer Marc, Lystig Ted, Kesten Steven, Tashkin Donald

Primary Institution: Baylor College of Medicine

Hypothesis

Does acute bronchodilator responsiveness predict long-term outcomes in COPD patients?

Conclusion

Acute bronchodilator responsiveness does not predict long-term health outcomes in COPD patients treated with tiotropium.

Supporting Evidence

  • 52% of patients exceeded the threshold for bronchodilator responsiveness using criterion A.
  • Statistically significant improvements in lung function were observed with tiotropium regardless of baseline bronchodilator responsiveness.
  • Only a small minority of patients remained nonresponsive across multiple visits.

Takeaway

The study found that many COPD patients show varying responses to bronchodilators over time, and this doesn't help doctors decide on treatment with tiotropium.

Methodology

Patients underwent spirometry before and after bronchodilator administration during the UPLIFT trial, with outcomes assessed based on bronchodilator responsiveness.

Potential Biases

Potential bias due to reliance on patient self-reporting for smoking adherence.

Limitations

The study could only measure bronchodilator responses in the placebo group due to the long half-life of tiotropium.

Participant Demographics

Mean age was 64 years, 75% male, and 30% current smokers.

Statistical Information

P-Value

p<0.001

Confidence Interval

Not specified

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1186/1465-9921-12-6

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication